Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Rheumatology 2, 648–649 (1 December 2006) | doi:10.1038/ncprheum0353
Do genetic variations in the adenosine pathway affect patient response to methotrexate?
Abstract
Wessels JAM et al. (2006) Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 54: 2830–2839 Synopsis Background Methotrexate is commonly used to treat patients with rheumatoid arthritis (RA), and has been shown to be most effective when therapy is initiated in early disease.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
